日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

Retrospective Analysis of the Correlation of MSI-h/dMMR Status and Response to Therapy for Endometrial Cancer: RAME Study, a Multicenter Experience

子宫内膜癌MSI-h/dMMR状态与治疗反应相关性的回顾性分析：RAME研究，一项多中心经验

期刊:Cancers
影响因子:4.4
doi:10.3390/cancers15143639
Tuninetti, Valentina; Pace, Luca; Ghisoni, Eleonora; Quarà, Virginia; Arezzo, Francesca; Palicelli, Andrea; Mandato, Vincenzo Dario; Geuna, Elena; Cormio, Gennaro; Biglia, Nicoletta; Borsotti, Lucia; Gallo, Silvia; Ferrero, Annamaria; Jacomuzzi, Elena; Fuso, Luca; Pezua Sanjinez, Jeremy Oscar Smith; Puppo, Andrea; Caglio, Andrea; Rognone, Chiara; Turinetto, Margherita; Scotto, Giulia; Di Maio, Massimo; Valabrega, Giorgio
肿瘤
子宫内膜癌
肿瘤免疫
多发性骨髓瘤
多发性硬化症
发表日期：2023
文献求助 收藏

Correction to: Real-world histopathological approach to malignancy of undefined primary origin (MUO) to diagnose cancers of unknown primary (CUPs)

更正：真实世界中针对原发灶不明恶性肿瘤（MUO）的组织病理学方法，用于诊断原发灶不明的癌症（CUP）

期刊:Virchows Archiv
影响因子:3.1
doi:10.1007/s00428-022-03475-5
Pisacane, Alberto; Cascardi, Eliano; Berrino, Enrico; Polidori, Alessio; Sarotto, Ivana; Casorzo, Laura; Panero, Mara; Boccaccio, Carla; Verginelli, Federica; Benvenuti, Silvia; Dellino, Miriam; Comoglio, Paolo; Montemurro, Filippo; Geuna, Elena; Marchiò, Caterina; Sapino, Anna
肿瘤
肿瘤免疫
发表日期：2023
文献求助 收藏

Real-World Clinical Outcomes of Ribociclib in Combination with a Non-Steroidal Aromatase Inhibitor and a Luteinizing Hormone-Releasing Hormone Agonist in Premenopausal HR+/HER2- Advanced Breast Cancer Patients: An Italian Managed Access Program

瑞博西尼联合非甾体类芳香化酶抑制剂和促黄体生成素释放激素激动剂治疗绝经前HR+/HER2-晚期乳腺癌患者的真实世界临床结果：一项意大利管理式准入计划

期刊:Current Oncology
影响因子:3.4
doi:10.3390/curroncol29090521
Staropoli, Nicoletta; Geuna, Elena; Rinaldi, Gaetana; Bisagni, Giancarlo; Scotti, Vieri; Faggioni, Giovanni; Vannini, Laura; Arcara, Carlo; Moretti, Gabriella; Gunnellini, Marco; Coltelli, Luigi; Verderame, Francesco; Livi, Lorenzo; Sanna, Giuseppina; Grasso, Donatella; Abbinante, Giulia; Ragni, Francesca
肿瘤
HER2
肿瘤免疫
乳腺癌
免疫/内分泌
发表日期：2022
文献求助 收藏

Cancer of unknown primary stem-like cells model multi-organ metastasis and unveil liability to MEK inhibition.

未知原发干细胞样细胞癌模拟多器官转移，并揭示了对 MEK 抑制剂的敏感性

期刊:Nature Communications
影响因子:15.7
doi:10.1038/s41467-021-22643-w
Verginelli Federica, Pisacane Alberto, Gambardella Gennaro, D'Ambrosio Antonio, Candiello Ermes, Ferrio Marco, Panero Mara, Casorzo Laura, Benvenuti Silvia, Cascardi Eliano, Senetta Rebecca, Geuna Elena, Ballabio Andrea, Montemurro Filippo, Sapino Anna, Comoglio Paolo M, Boccaccio Carla
发育与干细胞
细胞生物学
发表日期：2021
文献求助 收藏

The Clinical Efficacy and Safety of Neratinib in Combination with Capecitabine for the Treatment of Adult Patients with Advanced or Metastatic HER2-Positive Breast Cancer

奈拉替尼联合卡培他滨治疗HER2阳性晚期或转移性乳腺癌成人患者的临床疗效和安全性

期刊:Drug Design Development and Therapy
影响因子:5.1
doi:10.2147/DDDT.S281599
Chilà, Giovanna; Guarini, Vincenzo; Galizia, Danilo; Geuna, Elena; Montemurro, Filippo
HER2
肿瘤
肿瘤免疫
乳腺癌
发表日期：2021
文献求助 收藏

Cancer of Unknown Primary (CUP): genetic evidence for a novel nosological entity? A case report

原发灶不明癌（CUP）：一种新的疾病实体的遗传学证据？病例报告

期刊:EMBO Molecular Medicine
影响因子:8.3
doi:10.15252/emmm.201911756
Benvenuti, Silvia; Milan, Melissa; Geuna, Elena; Pisacane, Alberto; Senetta, Rebecca; Gambardella, Gennaro; Stella, Giulia M; Montemurro, Filippo; Sapino, Anna; Boccaccio, Carla; Comoglio, Paolo M
肿瘤
肿瘤免疫
发表日期：2020
文献求助 收藏

Exploratory analysis of circulating cytokines in patients with metastatic breast cancer treated with eribulin: the TRANSERI-GONO (Gruppo Oncologico del Nord Ovest) study

对接受艾立布林治疗的转移性乳腺癌患者循环细胞因子的探索性分析：TRANSERI-GONO（西北肿瘤协作组）研究

期刊:ESMO Open
影响因子:8.3
doi:10.1136/esmoopen-2020-000876
Garrone, Ornella; Michelotti, Andrea; Paccagnella, Matteo; Montemurro, Filippo; Vandone, Anna Maria; Abbona, Andrea; Geuna, Elena; Vanella, Paola; De Angelis, Claudia; Lo Nigro, Cristiana; Falletta, Antonella; Crosetto, Nicola; Di Maio, Massimo; Merlano, Marco
肿瘤
肿瘤免疫
RAN
乳腺癌
细胞生物学
免疫/内分泌
发表日期：2020
文献求助 收藏

MiR-100 is a predictor of endocrine responsiveness and prognosis in patients with operable luminal breast cancer

miR-100是可手术管腔型乳腺癌患者内分泌反应性和预后的预测因子

期刊:ESMO Open
影响因子:8.3
doi:10.1136/esmoopen-2020-000937
Petrelli, Annalisa; Bellomo, Sara Erika; Sarotto, Ivana; Kubatzki, Franziska; Sgandurra, Paola; Maggiorotto, Furio; Di Virgilio, Maria Rosaria; Ponzone, Riccardo; Geuna, Elena; Galizia, Danilo; Nuzzo, Anna Maria; Medico, Enzo; Miglio, Umberto; Berrino, Enrico; Venesio, Tiziana; Ribisi, Salvatore; Provero, Paolo; Sapino, Anna; Giordano, Silvia; Montemurro, Filippo
肿瘤
肿瘤免疫
乳腺癌
发表日期：2020
文献求助 收藏

Treatment with Beta-Blockers and ACE-Inhibitors in Breast Cancer Patients Receiving Adjuvant Trastuzumab-Based Therapy and Developing Mild Cardiac Toxicity: A Prospective Study

接受曲妥珠单抗辅助治疗的乳腺癌患者使用β受体阻滞剂和ACE抑制剂治疗后出现轻度心脏毒性：一项前瞻性研究

期刊:Cancers
影响因子:4.4
doi:10.3390/cancers12020327
Geuna, Elena; Lombardi, Pasquale; Martinello, Rossella; Garino, Davide; Bonzano, Alessandro; Galizia, Danilo; Nuzzo, Annamaria; Berchialla, Paola; Becco, Paolo; Mangioni, Monica; Zarlo, Lorena De; Montemurro, Filippo
信号转导
乳腺癌
毒理研究
肿瘤
肿瘤免疫
发表日期：2020
文献求助 收藏

"Metastatic Cancer of Unknown Primary" or "Primary Metastatic Cancer"?

“原发灶不明的转移性癌症”还是“原发性转移性癌症”？

期刊:Frontiers in Oncology
影响因子:3.3
doi:10.3389/fonc.2019.01546
Kolling, Stefan; Ventre, Ferdinando; Geuna, Elena; Milan, Melissa; Pisacane, Alberto; Boccaccio, Carla; Sapino, Anna; Montemurro, Filippo
肿瘤
肿瘤免疫
发表日期：2019
文献求助 收藏